Thermo Fisher Scientific Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit

Thermo Fisher Scientific has launched the CE-IVD marked Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit. Based on Sanger sequencing, the test examines positive HIV samples to identify genetic variants that may resist common antiretroviral therapeutics. The assay works with HIV RNA extracted from plasma or dried blood spots and is designed to detect genomic mutations in the protease, reverse transcriptase, and integrase regions of the HIV-1 pol gene across nine subtypes of global significance. According to Thermo Fisher, the kit obtained its CE-IVD mark in May 2022.